Jul 25, 2024 / 12:30PM GMT
Thomas Kudsk - Sanofi SA - Investor Relations
(audio in progress) usual forward-looking statements. We'd like to remind you that the information presented in this call contains forward-looking statements, which is subject to substantial risks and uncertainties that may cause actual results to differ materially. We encourage you to read the disclaimer in our slide presentation. In addition, we refer you to the Form 20-F file with the US SEC on d'Enregistrement document for a description of these risk factors.
As usual, we'll be making comments on our performance using constant statements and other non-IFRS measures. Numbers used are in million euros and for Q2 2024 unless stated otherwise.
Please turn to slide 4. First, we have a presentation then we take your questions. We have kept the presentation short as other companies report today and we aim at keeping the call to maximum one hour.
For Q&A, we have Brian, Olivier, Thomas, and Julie to cover the global business units and Roy, our General Counsel.
For the Q&A, you have two options in Zoom, raise your hand
Q2 2024 Sanofi SA Earnings Call Transcript
Jul 25, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers